Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
http://www.hepalink.com/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Therapeutic Endoscopy: ‘We’re At The Start Of What’s Possible’
In the emerging field of therapeutic endoscopy, Creo Medical’s Speedboat devices are advancing minimally invasive treatment by combining advanced bipolar radiofrequency and super high frequency microwave energy in a single device, says CTO and founder Chris Hancock.
Therapeutic Endoscopy: ‘We’re At The Start Of What’s Possible’
In the emerging field of therapeutic endoscopy, Creo Medical’s Speedboat devices are advancing minimally invasive treatment by combining advanced bipolar radiofrequency and super high frequency microwave energy in a single device, says CTO and founder Chris Hancock.
Deal Watch: Japan’s JCR Inks Pacts With Sumitomo Dainippon, Alexion
Agreement with Alexion is JCR’s first international deal for its blood-brain barrier drug delivery technology. Sartoris buys PolyPlus from private equity investors.
Hepalink-Backed HighTide Bets On NASH For Global Markets
Emerging Company Profile: Fatty liver disease has been a hot development area that keeps getting more attention, and one Chinese startup backed by the world’s largest heparin manufacturer is looking to launch a new therapy globally.
Company Information
- Industry
- Distributors
- Pharmaceuticals
-
Services
- Group Purchasing
- Home Infusion
- Other Names / Subsidiaries
-
- Cytovance Biologics
- Hepalink USA Inc.
- Shenzhen Hepalink Pharmaceutical Co., Ltd
- Shenzhen Arimab Biopharmaceuticals Co., Ltd.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice